Webinar reviews unique advantages of ePRO data in global diabetes programs

Patient-reported outcome (PRO) and electronic PRO (ePRO) measures are standard tools for directly eliciting the patient experience for Clinical Outcome Assessments (COAs). The 2009 FDA Guidance for Industry Patient Reported Outcome Measures: Use in Medical Product Development to Support Label Claims highlights the importance of PROs and other Clinical Outcome Assessment (COAs) in clinical research. Increasingly, diabetes therapies have been leveraging COAs and electronic COAs to demonstrate treatment benefit for patients.

This one-hour webinar is designed for professionals in protocol development, health outcomes, medical affairs, diabetes, regulatory affairs, clinical operations, and data management. It will review findings from multiple global diabetes programs, and reveal how capture of blood glucose levels by finger stick monitoring integrated with a handheld electronic device:

• Obviates hypoglycemia underreporting and inaccuracies
• Generates blood glucose frequency data that conforms to a more Gaussian distribution of continuous glucose monitoring (CGM) than paper data
• Shows an incidence rate of hypoglycemia that is in line with CGM

At the conclusion of the webinar, participants will understand:

• Key benefits of electronic collection of blood glucose measures
• Parallels between electronic self-monitoring and continuous monitoring of blood glucose
• Improved data completeness and quality with electronic capture versus paper